Skip to content

Clinical trials

Observational ST Elevation Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: ST Elevation Myocardial Infarction Phase: Observational Clear all

293 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20033
20041
20052
20065
20076
20082
20094
20106
201110
201210
201310
201416
201523
201616
201717
201820
201915
202015
202113
202219
202320
202419
202518
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed126
Unknown status89
Recruiting35
Not yet recruiting23
Active, not recruiting7
Terminated6
Withdrawn6
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University28
Chinese PLA General Hospital9
Aristotle University Of Thessaloniki5
Beijing Friendship Hospital5
RenJi Hospital4
Samsung Medical Center4
University College, London4
Biosensors Europe SA3
Cairo University3
Central Hospital, Nancy, France3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
ST Elevation Myocardial Infarction293
Non-ST Elevated Myocardial Infarction87
Myocardial Infarction54
Acute Coronary Syndrome42
Coronary Artery Disease39
Angina, Unstable28
Ischemia18
Myocardial Ischemia17
Angina Pectoris16
Angina, Stable16

Trials

Showing 1 to 25 of 293. Each trial links to its page on Pharma Observatory.

193 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.